Related Experiment Video
Updated: Apr 4, 2026
09:47
A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
Published on: April 26, 2015
16.5K
[CARDIOPROTFETIVE EFECTS OF NECROSTATIN-7 IN THE RAT MODEL OF PERMANENT CORONARY OCCLUSION]
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova
|September 5, 2015
Summary
Necrostatin-7, a necroptosis inhibitor, demonstrated cardioprotective effects in a rat model. Pretreatment reduced heart scar tissue and improved left ventricular function, suggesting therapeutic potential for myocardial infarction.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Pharmacology
Context:
- Myocardial infarction (MI) leads to significant cardiac damage and dysfunction.
- Necroptosis is an inflammatory form of programmed cell death implicated in ischemic injury.
- Targeting necroptosis presents a potential therapeutic strategy for limiting infarct size.
Purpose:
- To investigate the cardioprotective efficacy of necrostatin-7, a specific necroptosis inhibitor.
- To evaluate the impact of necrostatin-7 on infarct size and cardiac function in a rat model of permanent coronary occlusion.
Summary:
- Necrostatin-7 administration (14.5 mg/kg, intraperitoneal) 60 minutes before permanent coronary artery ligation in rats.
- Reduced left ventricular scar tissue and scar length by day 21 post-surgery.
- Decreased plasma levels of N-terminal pro-brain natriuretic peptide, indicating improved left ventricular function.
Impact:
- Necrostatin-7 exhibits significant cardioprotective properties in a preclinical model of myocardial infarction.
- Inhibition of necroptosis may be a viable therapeutic approach to mitigate ischemic heart damage.
- Further research into necrostatin-7 could lead to novel treatments for heart attack patients.
